ID
EMTECH
Emerging Technologies
Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.
The vision-restoring device will be implanted in humans within six to 12 months, following a successful monkey implantation that has remained active for three years, Musk said.
Anne Osdoit, CEO of Moon Surgical, discusses the company’s Maestro surgical robotics system and how it supports surgeons during soft tissue procedures.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
Nissan Elimelech, founder of Augmedics, discusses the process of developing augmented reality surgical navigation technology and his next endeavor to develop the first AR glasses specifically for healthcare.
What they offer is not a passive but an active clinical assistant that thinks beyond consultation notes.
Trained on two million skin images, it can perform a range of clinical tasks unlike current models.
Paul Grand, CEO of MedTech Innovator, discusses how the accelerator embraces high-risk, high-reward technologies and steers them to market with industry expertise.
The partnership combines Atropos Health's expertise in real-world evidence generation with Databricks' data intelligence capabilities.
Molly Gibson, president of future science at Lila Sciences, explains how the company's superintelligence will reshape research across life, chemical and material sciences.